EP Patent

EP1990048A3 — Therapy of benign prostatic hyperplasia (bph)

Assigned to Individual · Expires 2009-05-06 · 17y expired

What this patent protects

The present invention relates to the use of immunomodulatory and/or immunosuppressive substances for the therapy of benign prostate hyperplasia (BPH) and non-bacterial prostatitis.

USPTO Abstract

The present invention relates to the use of immunomodulatory and/or immunosuppressive substances for the therapy of benign prostate hyperplasia (BPH) and non-bacterial prostatitis.

Drugs covered by this patent

Patent Metadata

Patent number
EP1990048A3
Jurisdiction
EP
Classification
—
Expires
2009-05-06
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.